2results about How to "Enhanced osteogenic properties" patented technology

The present application relates to the field of medical materials, in particular to a preparation method of high-performance medical tantalum coating. A thin-size-low-diffusion tantalum coating is prepared on the surface of a porous titanium alloy substrate by a chemical vapor deposition method through a halide reaction of hydrogen reduction of metallic tantalum; there is an alloy element interdiffusion zone between the tantalum coating and the porous titanium alloy substrate, and the thickness of the interdiffusion zone is less than the thickness of the tantalum coating. The present application obtains a high-performance thin-size tantalum coating with high purity, small grain size and controllable transition layer suitable for the porous titanium alloy substrate, has higher preparation efficiency and lower cost, realizes high bonding strength of the coating and simultaneous improvement of the strength and plasticity of the porous titanium alloy, avoids dissolution of toxic metal ions such as Al and V, and improves biocompatibility and osteogenic performance. The new tantalum coating porous titanium alloy implant device has obvious advantages of higher mechanical, chemical and biological safety and lower cost, and is suitable for the fields of orthopedics, dental implants and tissue defect fillers.

This invention provides a biocompatible β This invention relates to a method for composite modification of titanium alloy surfaces, belonging to the technical field of alloy modification methods. The invention includes applications in medical... β This invention involves introducing bioactive particles onto the surface of a titanium alloy substrate, performing friction stir processing (FSP) on the substrate to introduce bioactive particles and construct a gradient grain structure, and then subjecting the FSP-treated substrate to compressed plasma flow (CPF) treatment to achieve uniform distribution of bioactive particles and construct a topology with an average surface roughness of 3-6 μm suitable for cell growth. The invention precisely controls the amount of bioactive particles introduced and constructs a gradient grain structure through friction stir processing (FSP); simultaneously, compressed plasma flow (CPF) technology achieves uniform distribution of bioactive particles and an ideal surface roughness of 3-6 μm on the titanium alloy surface. Ultimately, this significantly improves the cell adhesion, proliferation capacity, and osteogenic properties of the material surface, solving the technical problem of low integration efficiency of traditional titanium alloy implants with human bone tissue.